Go Deep
Champions Oncology, Inc.
Champions Oncology, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 11,032 | -68.7 | 17.20 | 2.46 | 456.70 |
| Oct 2026 | 11,080 | -68.4 | 17.13 | 2.46 | 454.86 |
| Oct 2026 | 11,297 | -67.1 | 16.80 | 2.46 | 445.16 |
| Oct 2026 | 11,321 | -67.0 | 16.77 | 2.46 | 444.69 |
| Oct 2026 | 11,052 | -68.7 | 17.20 | 2.46 | 456.07 |
| Oct 2026 | 10,956 | -69.3 | 17.34 | 2.46 | 458.72 |
| Oct 2026 | 11,172 | -68.0 | 17.02 | 2.46 | 449.30 |
Champions Oncology, Inc. Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 15,232,000.0 | 13,835,000.0 | 16,559,000.0 | 15,035,000.0 |
| Net Profit | -426,000.0 | -667,000.0 | -279,000.0 | 299,000.0 |
| EPS | -0.0 | — | -0.0 | 0.0 |
Champions Oncology, Inc. Revenue & Profit: Last 5 Years
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Revenue | 59,425,000.0 | 56,944,000.0 | 50,155,000.0 | 53,870,000.0 | — |
| Net Profit | -1,175,000.0 | 4,701,000.0 | -7,276,000.0 | -5,335,000.0 | — |
| EPS | -0.1 | 0.3 | -0.5 | -0.4 | — |
Champions Oncology, Inc. Balance Sheet
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Total Assets | 26,989,000.0 | 32,344,000.0 | 26,132,000.0 | 34,311,000.0 | — |
| Total Liabilities | 22,921,000.0 | 28,572,000.0 | 28,035,000.0 | 29,675,000.0 | — |
| Total Equity | 3,939,000.0 | 3,772,000.0 | -1,903,000.0 | 4,636,000.0 | — |
Owes vs Owns
Champions Oncology, Inc. owed $0.87 for every $1 it owned in Jul 2026, about the same as $0.86 in Apr 2023.
| Period | Jul 2026 | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.87× | 0.85× | 0.88× | 1.07× | 0.86× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Champions Oncology, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Apr 2026
Cash & short-term investments 18.1%Receivables 48.8%Fixed assets (tangible) 26.8%Intangible assets 1.2%Other assets 5.1%
How it's funded — Apr 2026
Short-term debt 5.6%Long-term debt 11.1%Payables 25.6%Other liabilities 42.6%Shareholders' equity 15.1%
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.9 | 9.8 | 2.6 | 10.1 |
| Receivables | 13.2 | 11.2 | 9.5 | 8.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 7.2 | 9.5 | 12.0 | 14.5 |
| Intangible assets | 0.3 | 0.3 | 0.3 | 0.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.4 | 1.6 | 1.7 | 1.3 |
| Liabilities & equity | ||||
| Short-term debt | 1.5 | 1.5 | 1.3 | 1.2 |
| Long-term debt | 3.0 | 4.6 | 6.1 | 7.4 |
| Payables | 6.9 | 4.2 | 5.8 | 5.3 |
| Other liabilities | 11.5 | 18.2 | 14.8 | 15.7 |
| Shareholders' equity | 4.1 | 3.8 | -1.9 | 4.6 |
| Net tangible assets | 3.6 | 3.4 | -2.2 | 4.3 |
Champions Oncology, Inc. Cash Flow
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Operating Activities | -4,472,000.0 | 7,386,000.0 | -6,137,000.0 | 3,972,000.0 | — |
| Investing Activities | -540,000.0 | -389,000.0 | -836,000.0 | -2,872,000.0 | — |
| Financing Activities | 99,000.0 | 170,000.0 | -527,000.0 | 11,000.0 | — |